Crossmark

Open‐Label, Multi‐Dose, Pilot Safety Study of Injection of OnabotulinumtoxinA Toward the Otic Ganglion for the Treatment of Intractable Chronic Cluster Headache

Crossref DOI link: https://doi.org/10.1111/head.13889

Published Online: 2020-06-25

Published Print: 2020-09

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Crespi, Joan

Bratbak, Daniel

Dodick, David W.

Matharu, Manjit

Solheim, Ole

Gulati, Sasha

Berntsen, Erik Magnus

Tronvik, Erling
Funding

Funding for this research was provided by:

Norges Teknisk-Naturvitenskapelige Universitet (46056923)
License Information

Version of Record valid from 2020-06-25
More Information

Publication History

Received: 2020-01-06

Accepted: 2020-05-18

Published: 2020-06-25

Document is current

Any future updates will be listed below